Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019 to 2020: Sichuan Cancer Hospital

Head Neck. 2020 Jun;42(6):1153-1158. doi: 10.1002/hed.26161. Epub 2020 May 1.

Abstract

Since December 2019, a number of patients with novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei Province, China. NCP has rapidly spread to other provinces and cities in China and other countries in the world. Due to the rapid increase in reported cases in China and around the world, on January 30, 2020, the World Health Organization (WHO) Emergency Committee announced that NCP is a Public Health Emergency of International Concern (PHEIC). However, there are relatively few suggestions and measures for tumor patients, especially patients with head and neck tumors. This article summarizes the prevention and control of disease in our medical institution to provide a reference for front-line head and neck surgeons.

Keywords: 2019 novel coronavirus diseases; head and neck tumor; infectious diseases; medical protection.

Publication types

  • Review

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Cancer Care Facilities / organization & administration*
  • China
  • Communicable Disease Control / organization & administration
  • Communicable Diseases / transmission*
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / prevention & control
  • Delivery of Health Care / organization & administration*
  • Emergencies / epidemiology
  • Emergency Service, Hospital / organization & administration
  • Female
  • Head and Neck Neoplasms / diagnosis
  • Head and Neck Neoplasms / epidemiology
  • Head and Neck Neoplasms / therapy*
  • Hospitals, Special / organization & administration
  • Humans
  • Male
  • Pandemics / prevention & control
  • Patient Safety
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / prevention & control
  • SARS-CoV-2
  • Triage